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Research
The development of nanotechnologies leads 
to the incorporation of nanomaterials into 
common consumer products because of the 
novelty and distinctive properties of mate­
rials at nanoscale. The number of nano­
technology­based consumer products listed 
in the Nanotechnology Consumer Products 
Inventory (Woodrow Wilson International 
Center for Scholars 2011a) is currently 
> 1,300. These products are manufactured 
by nearly 600 companies in 30 countries. 
Because this online database lists only a sub­
set of products advertised on the Internet as 
nanotechnology based (Woodrow Wilson 
International Center for Scholars 2011b), the 
actual number is probably higher. The expan­
sion of the nanotechnology­based consumer 
products market (Bradford et al. 2009; Kessler 
2011; Maynard 2007; Paull and Lyons 2008; 
Woodrow Wilson International Center for 
Scholars 2011b) is cause for concern regarding 
potential human exposure to nanomaterials 
and possible health risks. The potential for 
exposure is still poorly understood, and poten­
tial health effects are unknown (Drobne 2007; 
Frater et al. 2006; Segal 2004; Van Calster 
2006; Warheit et al. 2007). This impedes the 
development of appropriate consumer safety 
regulations and guidelines (Maynard et al. 
2006; Oberdörster et al. 2005a; Paull and 
Lyons 2008; Riediker 2009).
A nanoproduct’s type and intended use 
determine the most plausible routes and 
extent of exposure (Oberdörster et al. 2005b; 
Wardak et al. 2008). Use of nanotechnology­
  based cosmetic powders and sprays could lead 
to especially high levels of dermal and inhala­
tion exposure, the latter being a consequence 
of product application leading to aerosol 
generation in the personal breathing zone 
(Hansen et al. 2008; Shimada et al. 2009). 
Contradictory conclusions regarding der­
mal absorption and toxicity of nano  particles 
have been reported (Baroli 2009; Baroli et al. 
2007; Crosera et al. 2009; Larese et al. 2009; 
Senzui et al. 2010), and additional research 
has been recommended to better character­
ize and determine health concerns associated 
with dermal nanomaterial exposure (Crosera 
et al. 2009). At the same time, inhalation 
exposure to nanomaterials is a serious health 
concern (Savolainen et al. 2010). During 
consumer use, nanomaterials can be released 
and enter the respiratory system as free nano­
particles, nano  particle agglomerates, and 
nano  particles within or attached to larger par­
ticles. Additionally, other substances present 
in the applied nanoproduct could be physi­
cally transported on the nano  particles them­
selves (Nowack and Bucheli 2007).
Many studies investigating the toxic­
ity of pure nanomaterials have already been 
performed and summarized (Holgate 2010; 
Johnston et al. 2010; Marambio­Jones and 
Hoek 2010; Ostrowski et al. 2009; Savolainen 
et al. 2010; Schilling et al. 2010). However, 
the potential for consumer exposure to nano­
particles from actual nanotechnology­based 
products where nanomaterials exist in a prod­
uct matrix with other ingredients has so far 
been addressed to only a limited degree.
Potential exposures and associated health 
effects are expected to depend on the dis­
persed particle size, agglomeration state, 
surface area and chemistry, solubility, concen­
tration, and possibly the shape characteristics 
of nanomaterial(s) in a product (Bermudez 
et al. 2004; Shrader­Frechette 2007). Initial 
nanomaterial ingredients in consumer prod­
ucts might be chemically and physically 
modified through interactions with other 
ingredients in the product or through nano­
particle surface treatment during production, 
which may also affect their toxicity (Kessler 
2011; Warheit et al. 2005). Therefore, prop­
erties of original nanomaterial ingredients 
cannot serve as the sole basis for predicting 
exposure and health effects of a particular 
nanotechnology­based consumer product 
(Lioy et al. 2010; Maynard 2007). The size 
distribution of aerosol particles released and 
potentially inhaled during product use may 
also depend on the composition of the prod­
uct, which in turn would affect the deposition 
of nanomaterial(s) in the respiratory system. 
Address correspondence to G. Mainelis, Department 
of Environmental Sciences, Rutgers, the State 
University of New Jersey, 14 College Farm Rd., 
New Brunswick, NJ 08901 USA. Telephone: (732) 
932­9800, ext. 6208. Fax: (732) 932­8644. E­mail: 
mainelis@envsci.rutgers.edu
Supplemental Material is available online (http://
dx.doi.org/10.1289/ehp.1104350). 
This research was supported in part by the National 
Institute of Environmental Health Sciences–sponsored 
University of Medicine and Dentistry of New Jersey 
Center for Environmental Exposures and Disease 
(grant P30ES005022), a joint grant between the U.S. 
Environmental Protection Agency (grant 834693020) 
and the U.K. Natural Environment Research Council 
(grant NE/H012893), and the New Jersey Agriculture 
and Experiment Station at Rutgers University. 
The views expressed in this article are solely the 
authors’ and do not necessarily reflect those of the 
funding agencies.
The authors declare they have no actual or potential 
competing financial interests.
Received 17 August 2011; accepted 6 March 2012.
Potential for Inhalation Exposure to Engineered Nanoparticles 
from Nanotechnology-Based Cosmetic Powders
Yevgen Nazarenko,1 Huajun Zhen,1 Taewon Han,1 Paul J. Lioy,2,3 and Gediminas Mainelis1,3
1Department of Environmental Sciences, Rutgers University, the State University of New Jersey, New Brunswick, New Jersey, 
USA; 2Robert Wood Johnson Medical School–University of Medicine and Dentistry of New Jersey, Piscataway, New Jersey, USA; 
3Environmental and Occupational Health Sciences Institute, Robert Wood Johnson Medical School–University of Medicine and Dentistry 
of New Jersey and Rutgers University, Piscataway, New Jersey, USA
Ba c k g r o u n d: The market of nanotechnology-based consumer products is rapidly expanding, and 
the lack of scientific evidence describing the accompanying exposure and health risks stalls the dis-
cussion regarding its guidance and regulation.
oBjectives: We investigated the potential for human contact and inhalation exposure to nano-
materials when using nanotechnology-based cosmetic powders and compare them with analogous 
products not marketed as nanotechnology based.
Me t h o d s : We characterized the products using transmission electron microscopy (TEM) and 
laser diffraction spectroscopy and found nano  particles in five of six tested products. TEM photo-
micrographs showed highly agglomerated states of nano  particles in the products. We realistically 
simulated the use of cosmetic powders by applying them to the face of a human mannequin head 
while simultaneously sampling the released airborne particles through the ports installed in the 
mannequin’s nostrils.
re s u l t s: We found that a user would be exposed to nanomaterial predominantly through 
nanoparticle-  containing agglomerates larger than the 1–100-nm aerosol fraction.
co n c l u s i o n s: Predominant deposition of nanomaterial(s) will occur in the tracheobronchial 
and head airways—not in the alveolar region as would be expected based on the size of primary 
nanoparticles. This could potentially lead to different health effects than expected based on the 
current understanding of nano  particle behavior and toxicology studies for the alveolar region.
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Thus, one should characterize not only the in­
product nanomaterials but also their charac­
teristics during actual use by simulation and 
investigation of realistic exposure scenarios 
(Lioy 2010; Nazarenko et al. 2011).
In our earlier research, we investigated 
  nanotechnology­based consumer spray products 
as well as their regular, non–nanotechnology­
  based, counterparts in a realistic exposure sce­
nario, including a simulated application of the 
sprays (Nazarenko et al. 2011). The study dem­
onstrated the potential for inhalation exposure 
to nanosize particles from all investigated prod­
ucts. Release of airborne silver nano  particles 
during propellant­  facilitated spraying of one 
nanotechnology­  based silver spray was also 
shown in another study (Hagendorfer et al. 
2010). The magnitude and prevalence of such 
exposures and associated risks are still unknown 
(Bradford et al. 2009; Keenan et al. 2009; Lioy 
et al. 2010).
In this study we focused on cosmetic pow­
ders, including nanotechnology­based­ and 
non–nanotechnology­based powders, another 
category of consumer products with a high 
probability of inhalation exposure. The study 
had the following objectives: a) to characterize 
nano  particles in several nanotechnology­based 
cosmetic powders currently in the market, 
b) to determine the potential for exposures to 
airborne nano  particles and their agglomerates 
during the use of cosmetic powders in a realis­
tic exposure scenario, and c) to compare investi­
gated nanotechnology­based cosmetic powders 
with their regular (non­  nanotechnology) coun­
terparts. This study responds to the call for 
independent nanotechnology­based com­
mercial consumer product research, free of 
potential conflict of interest (Maynard 2007; 
Maynard and Aitken 2007; Michelson 2008; 
Shrader­Frechette 2007; Thomas et al. 2009).
To the best of our knowledge, this study 
is the first to determine the potential for 
human inhalation exposure to nanomaterials 
released from nanotechnology­based and regu­
lar cosmetic powders in a realistic exposure 
simulation.
Materials and Methods
Tested cosmetic powders. We selected three 
nanotechnology­based cosmetic powders 
(“nanopowders”)—a moisturizer, a blusher, 
and a loose powder sunscreen—from the 
Woodrow Wilson Nanotechnology Consumer 
Products Inventory (Woodrow Wilson 
International Center for Scholars 2011a) 
and acquired them from the manufacturers. 
Currently, reporting by the manufacturers is 
the only way to identify the “nano” status of 
the products, and it may not be a guarantee 
that any given product in the inventory con­
tains nanotechnological components (Hansen 
et al. 2008; Som et al. 2010). Consequently, 
the authors’ references to products in this 
project as “nanoproducts” or “nanopowders” 
are based on product’s presence in the above­
mentioned inventory as of 1 September 2008. 
Additionally, we selected three cosmetic pow­
ders that manufacturers do not claim include 
nanomaterial(s) (“regular powders”)—two 
blot powders and a finishing powder—and 
tested them for comparison with the cosmetic 
nanopowders. The selected regular powders 
perform functions similar to those of their 
nanotechnology­based counterparts and are 
also applied to the face.
The studied nano­ and regular products 
are listed in Supplemental Material, Table 1 
(http://dx.doi.org/10.1289/ehp.1104350), 
along with their intended application purpose 
and composition as reported by the manufac­
turers. We tested all products in their original 
formulation as shipped, without any deliber­
ate pre  treatment, deagglomeration, or any 
other type of modification. We replaced the 
product brand names with letter codes.
Characterization of cosmetic powders in 
their original state. Characterization of nano­
particles in the original products is neces­
sary because the size distribution of particles 
released during a simulated product application 
might differ from that in the original product 
and may not adequately reflect the nanomate­
rial content to which a user would be exposed. 
We analyzed the powders in their original state 
using transmission electron microscopy (TEM) 
and laser diffraction spectrometry (LDS).
TEM. We used a transmission elec­
tron microscope (model 2010F; JEOL Ltd., 
Tokyo, Japan) to determine the size, shape, 
and agglomeration of electron­contrast parti­
cles [those visible in TEM photo  micrographs; 
see Supplemental Material, p. 5 (http://dx.doi.
org/10.1289/ehp.1104350)] in the tested pow­
ders. We spread small quantities of each prod­
uct on HC300­Cu grids (Electron Microscopy 
Sciences, Hatfield, PA) and performed manual 
particle size measurement (Matyi et al. 1987) 
from the resulting photo  micrographs using 
the automatically inserted scale marks.
Laser diffraction spectrometry.  We 
used a laser diffraction particle size analyzer 
(Mastersizer 2000; Malvern Instruments Ltd., 
Worcestershire, UK) with a dry powder feeder 
(Scirocco 2000; Malvern Instruments Ltd.) to 
disperse the cosmetic powders in the air inside 
the device and determine their particle size 
distributions. The dry powder feeder employs 
a vibrating tray, which continuously feeds a 
powder into a Venturi tube, where it is accel­
erated close to the speed of sound. This sepa­
rates loose agglomerates by shear forces (Jones 
2002). Mastersizer 2000 uses the red helium 
neon laser (633 nm) to measure particle size 
from 2,000 μm down to 100 nm (Malvern 
Instruments Ltd. 2011). Additional informa­
tion is provided in the Supplemental Material, 
p. 5 (http://dx.doi.org/10.1289/ehp.1104350).
The size distributions were generated by 
the Malvern Application (version 5.60) using 
the general purpose enhanced model for fine 
powders. All but one (i.e., regular powder E) 
of the products are mixtures of substances 
with different refractive indexes (RIs). The RI 
used in LDS is mathematically expressed as a 
complex number consisting of real and imagi­
nary parts. The real part is the ratio of phase 
velocity of light in vacuum versus phase veloc­
ity of light in the bulk material, whereas the 
imaginary part, which describes absorption, 
depends on the nature and shape of particles 
(Gillespie and Lindberg 1992). Although the 
RIs of calcium carbonate, talc, and silica are 
around 1.5–1.7, the RI of titanium dioxide, a 
component of many cosmetic powders includ­
ing one of the products tested in this study 
(nanopowder K), is 2.741. Because LDS per­
forms analysis of a given powder based on a 
single RI, the accuracy of measurements may 
be undermined depending on the selected RI 
when particles with different RIs are present. 
To minimize the measurement error, and on 
the basis of the composition of the cosmetic 
powders [see Supplemental Material, Table 1 
(http://dx.doi.org/10.1289/ehp.1104350)], 
we chose to perform our analyses using the 
RI of silica (1.544) for all powders with the 
exception of nanopowder K, for which we 
used the RI of zinc oxide (2.0041), which is a 
second active ingredient in this product along 
with titanium dioxide. This was considered 
a reasonable approach because the manufac­
turer did not provide the full composition 
of nanopowder K but listed only the active 
ingredients constituting 45% of the prod­
uct: the nature of the remaining 55% of the 
product’s ingredients remained unknown. The 
imaginary RI could not be determined for the 
products experimentally, so we used the imagi­
nary RI value of 0.1 as advised in the Malvern 
Application for ground transparent materials 
(Malvern Instruments Ltd.).
Simulated application of cosmetic   powders. 
We realistically simulated the application of 
cosmetic powders and the resulting inhalation 
exposures using the experimental setup shown 
in Figure 1. We placed a human female 
manne  quin head (Image Supply House, 
Endicott, NY) inside a custom­built glove 
box with a removable cover. The inner dimen­
sions of the glove box were 56 × 33 × 39 cm3 
(approximately 72 L), and we covered its 
inner walls with aluminum foil to reduce 
electrostatic effects. We placed the glove box 
inside a level 2 biosafety cabinet (NUAIRE 
Inc., Plymouth, MN) with inner dimensions 
of 178.4 cm wide × 71.8 cm high × 57.2 cm 
diameter. We removed the top cover of the 
glove box for 5 min immediately before 
each experiment, to bring the concentration 
of background particles to below the detec­
tion limit of the instruments used, and then Exposure to nanoparticles from cosmetic powders
Environmental Health Perspectives  •  v o l u m e  120 | n u m b e r 6 | June 2012  887
replaced it. We operated the HEPA filtration 
system of the biosafety cabinet continuously 
throughout the powder application experi­
ments. The glove box had two air inlets open 
to the inside of the biosafety cabinet to replace 
the air removed from the box by the measure­
ment devices with particle­free air.
We applied all powders to the face of the 
mannequin head in a way that simulated actual 
product usage, using brushes or pads included 
with each product. Because the manufactur­
ers did not include applicators with nano­
powder M and regular powder E, we applied 
these two products using identical Kabuki 
brushes (Sephora USA Inc., San Francisco, 
CA). Additionally, we used a new Kabuki 
brush without any powder for comparison. 
After each application, we thoroughly cleaned 
the mannequin’s face with 70% vol denatured 
ethanol. We performed background (i.e., no 
manipulations in the glove box) control meas­
urements between the product tests.
Measurement of released particles. We 
installed two stainless steel tubes with an inner 
diameter of 5 mm into the nostrils of the 
manne  quin head to sample the particles that 
would be inhaled during the application of 
the powders. The two aerosol streams drawn 
through the mannequin’s nostrils were com­
bined into one at the mannequin’s nape using 
a stainless steel Y­connector, fitted through the 
back wall of the glove box, and then split using 
a stainless steel flow splitter (model 3708; TSI 
Inc., Shoreview, MN) and drawn into a scan­
ning mobility particle sizer (SMPS) (module 
combination 3080/3786; TSI Inc.) and an aer­
sol particle sizer (APS; model 3321; TSI Inc.) 
via conductive tubing. These devices measured 
the actual airborne particle size distribution 
presented to the human respiratory system for 
inhalation, which is crucial for quantitative 
nanomaterial exposure assessment. The aspira­
tion rate of the SMPS, QSMPS, was 0.3 L/min, 
and that of the APS, QAPS, was 4.7 L/min. An 
additional pump provided an auxiliary aspira­
tion rate, Qaux, of 6.0 L/min, thus resulting in 
the total sampling flow rate Qa = 11.0 L/min, 
which corresponds to the breathing rate recom­
mended for assessing short­term exposures 
for an 18­ to 60­year­old female performing 
light activity (U.S. Environmental Protection 
Agency 1997) [see Supplemental Material, p. 5 
(http://dx.doi.org/10.1289/ehp.1104350)]. All 
connectors and sampling lines were of conduc­
tive material, and as short and as vertical as 
possible, to minimize potential particle losses.
Because the SMPS provides a full scan of 
the entire size range in 3 min, we continu­
ously and to the best of our ability uniformly 
applied each test powder during this time 
period. The APS measured particle concen­
tration in all size bins simultaneously every 
  second and provided an average concentration 
for each 3­min interval.
We used the SMPS system with a built­in 
0.0457­cm impactor (D50 = 0.656 μm). This 
allowed us to obtain particle size distributions 
of 14.1–723 nm, whereas the APS measured 
particles in the 0.6–19.8 μm (600–19,800 nm) 
range. The measured particle size distributions 
by number are presented as ΔN/ΔlogDp per 
cubic centimeter, where ΔN is the number of 
particles detected in a size channel and ΔlogDp 
is the difference between the logarithms of 
the upper and lower channel diameters. The 
SMPS and APS measure electrical mobil­
ity and aerodynamic diameters, respectively, 
which are identical for spherical particles of 
1 g/cm3 density. We assumed that all of the 
airborne powder particles had a density of 
1 g/cm3, which we considered to be a reason­
able approach because all investigated powders 
except regular powder E were composites of 
multiple materials, mixed in mostly unknown 
proportions. Therefore, we interpreted SMPS 
and APS data as measurements on the same 
particle­size scale.
We subtracted the background particle 
concentration data from each set of APS 
measurements. The SMPS measurements 
indicated particle concentrations below the 
detection limit in the overwhelming majority 
of size channels for the background and clean 
brush measurements. We tested each powder 
three times in randomized order and calcu­
lated the average particle­number–based size 
distributions for each powder and instrument.
Results and Discussion
Analysis of powders. TEM analysis. TEM 
allows for direct viewing of solid electron­
  contrast primary nano  particles or their agglom­
erates in consumer products. Representative 
TEM photo  micrographs of tested powders 
are presented in Figure 2, and the summary of 
the TEM image analysis results is presented in 
Table 1. We found electron­contrast particles in 
all of the tested powders. The electron beam did 
not appear to alter the structure of any of the 
particles observed [see Supplemental Material, 
p. 6 (http://dx.doi.org/10.1289/ehp.1104350)].
All the primary particles (i.e., particles 
constituting the smallest dispersion level) in 
the sample of nanopowder M (Figure 2A–C) 
were in the nanosize range. In fact, the larg­
est observed particle was 45 nm in diameter. 
No free nano  particles or individual agglomer­
ates were observed—the level of agglomeration 
was very high, because all the nano  particles in 
the samples of this product were continuously 
interconnected on the TEM grids. The sample 
of nano  powder D (Figure 2D–F) contained 
no electron­  contrast particles in the nanosize 
range. The only particles observed were > 5 μm 
(5,000 nm) in diameter and were not agglomer­
ated. Nanopowder K (Figure 2G–I) contained 
a wide size range of highly agglomerated par­
ticles, with most primary particles being in the 
nanosize range. Close examination of photo­
micrographs for regular powder F (Figure 2J–L) 
showed nanosize particles in contact with larger 
particles. In the photo  micrographs of regular 
powder G (Figure 2M–O), most of the surface 
of the TEM grid was covered with particles 
> 5 μm in diameter, with only a few separate 
nano  particles. Regular powder E (Figure 2P–R) 
contained a large number of nano  particles 
that were agglomerated and attached to 
larger particles.
Based on the composition of the pow­
ders as provided by the manufacturers [see 
Supplemental Material, Table 1 (http://
dx.doi.org/10.1289/ehp.1104350)], we expect 
that the observed electron­contrast particles, 
including nano  particles, contained silica (in 
all products with a possible exception of nano­
powder K, for which information on compo­
sition was incomplete), talc (nanopowder D 
and regular powder G), mica (nanopowder D 
and regular powder F), aluminum hydroxide 
(nanopowder D), titanium dioxide and zinc 
oxide (nanopowder K), or kaolin and iron 
oxides (regular powders F and G).
Overall, based on TEM, we observed the 
highest abundance of nano  particles in nano­
powders M and K and in regular powder E.
LDS analysis. The summarized results of 
the LDS analysis are listed in Table 1. The 
Figure 1. Experimental setup for simulated cosmetic powder application and measurement of resulting 
aerosol. Qa, total sampling flow rate; QAPS, aspiration rate of the APS; Qaux, auxiliary aspiration rate; QSMPS, 
aspiration rate of the SMPS.
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instrument detected particles of 100 nm 
in nanopowders M and K and in regular 
powders F, G, and E. Size distributions of 
particles in these five powders were simi­
lar in shape, and all had mode diameters of 
0.33 μm. Nanopowder D had a mode diam­
eter of 0.66 μm (Figure 3).
Because the lower size limit of the LDS 
instrument used was 100 nm, particles 
with smaller diameter would not have been 
observed. However, the size distributions 
of these powders suggest that particles with 
diameters < 100 nm were likely present as 
well (Figure 3). This assumption is supported 
by the fact that TEM also registered particles 
< 100 nm in these five products.
Notably, neither TEM nor LDS indicated 
nano  particles in nanopowder D, which is mar­
keted as nanotechnology based. Conversely, 
the same analysis techniques detected a high 
number of nano  particles in regular powder E, 
which is not marketed as nanotechnology 
based. These findings suggest that information 
provided regarding the presence or absence 
of nanomaterials in consumer products may 
not always be confirmed by experimental 
  techniques.
Analysis of airborne particles released 
during powder application. The size distribu­
tions and concentrations of aerosol particles 
released during the simulated application of 
cosmetic powders based on SMPS and APS 
are presented in Figure 4. The mode diam­
eters of the released particle size distributions 
that were sampled through the mannequin’s 
nostrils are provided in Table 1.
A detailed description of the particle size 
distributions is provided in Supplemental 
Material [see Supplemental Results, “Airborne 
Particle Measurement Results” (http://dx.doi.
org/10.1289/ehp.1104350)]. In brief, for par­
ticles < 25 nm in diameter, which are charac­
terized by higher alveolar deposition efficiency 
compared with larger particles (International 
Commission on Radiological Protection 
1994), more variance in particle concentra­
tion was observed for nanopowders M and 
D and regular powders F and G (Figure 4A) 
than for the rest of the products. The SMPS 
system is very sensitive to fluctuating particle 
concentrations. Therefore, we concluded that 
for these four cosmetic powders (M, D, F, and 
G), airborne nano  particle concentration in the 
region < 25 nm in diameter was unstable over 
the course of cosmetic powder application. 
In general, peak nano  particle number con­
centrations for particles < 25 nm in diameter 
were comparable to the highest concentrations 
observed for particles that were 25–723 nm 
in diameter.
Concentrations of nano  particles between 
25 and 100 nm in diameter differed among 
products (Figure 4A). It is notable that the 
highest total particle counts were measured 
Figure 2. TEM photo  micrographs of the tested cosmetic nanopowders (Nano) M (A–C), Nano D (D–F), and 
Nano K (G–I) and tested cosmetic regular powders (Reg) F (J–L), Reg G (M–O), and Reg E (P–R).
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during the application of regular powder E, 
which is not marketed as a nanotechnology­
  based product by its manufacturer. Never­
theless, the spherical shape of the silica particles 
observed in this cosmetic powder using TEM 
(Figure 2B, P–R) suggests that they may have 
been engineered, which, if true, would make 
this product de facto nanotechnology based.
Airborne concentrations of particles 
between 100 nm and 20 μm in diameter 
(Figure 4) varied substantially among the 
different cosmetic powders. Particles across 
this entire range were measured during the 
application of both nanotechnology­based 
powders and regular powders, without obvi­
ous differences in the distributions between 
the nano  powders and regular powders. The 
products with the highest and lowest airborne 
concentrations varied within different par­
ticle size modes: fine (0.1–1 μm), accumula­
tion (1–2.5 μm), coarse (2.5–10 μm), and 
supercoarse (> 10 μm), as defined by Lioy 
et al. (2006) (Figure 4B). Notably, for particle 
diameters > approximately 1.5 μm, regular 
power E had the highest concentrations and 
nanopowder M had the lowest concentra­
tions [for additional details, see Supplemental 
Material, pp. 6–7 (http://dx.doi.org/10.1289/
ehp.1104350)].
It is important to note, however, that appli­
cation of all nanopowders resulted in the release 
of particles as large as 20 μm (Figure 4B), and 
judging from the size distribution, even larger 
particles may have been released. As shown by 
the electron microscopy (Figure 2), the nano­
particles were agglomerated in the cosmetic 
powders, which suggests that nanomaterial 
may have been present in all airborne particle 
size fractions generated in the personal breath­
ing cloud by cosmetic powder application.
SMPS (Figure 4A) and APS (Figure 4B) 
measurements in the overlapping size range 
(500–700 nm or 0.5–0.7 μm) do not always 
agree. A discussion of potential causes for such 
differences is provided elsewhere (Nazarenko 
et al. 2011).
Implications for exposure assessment and 
health risks. Although deposition in the alveo­
lar region of the lung is the highest for nano­
particles and agglomerates of nano  particles 
< 100 nm in diameter, particles larger than 
approximately 0.3 μm (300 nm) in diam­
eter can efficiently deposit in the non–gas­
exchange region of the lung, with particles 
> 10 μm in diameter (supercoarse particles) 
depositing primarily in the head airways 
(Hinds 1999). Therefore, inhalation of aero­
sol particles containing nanomaterials in both 
the 1–100 nm and 100 nm to 20 μm diam­
eter size ranges, and possibly larger, and their 
potential deposition in all regions of the respi­
ratory system, should be considered.
Our TEM data showed a predominance 
of agglomerated nano  particles in nano­
powders M and K, and a high number of 
agglomerated nano  particles that were in con­
tact with the surface of larger particles in regu­
lar powder E. Based on the TEM and aerosol 
measurement data, we expect that most of the 
airborne nanomaterial from cosmetic pow­
ders, especially by mass [see Supplemental 
Material, Figure 1 (http://dx.doi.org/10.1289/
ehp.1104350)], will be in agglomerated form 
in particle size fractions > 100 nm, which 
Table 1. Characteristics of the tested cosmetic powder products obtained using different analysis methods.
LDS diameter Mannequin sampling mode 
diameter Smallest detected 
particle (nm)
Mode 
(μm) Product Summary of TEM resultsa Presence of particles < 100 nm SMPS (nm) APS (μm)
Nanopowdersb
M 6–45 nm, only agglomerates, fused spheroidal 
and irregular, solid, beam insensitive
All particles are < 100 nm and 
agglomerated
100 0.33 < 100 1.7
D > 5 μm, single particles, irregular, solid, beam 
insensitive
Not observed 440 0.66 < 100 1.0
K 7 nm to > 3 μm, only agglomerates, angular 
spheroidal, solid, beam insensitive
Many agglomerated particles < 100 nm 100 0.33 53.3, 101.8, 241.4, 
358.7
1.5
Regular powders
F 12 nm to > 8.8 μm, single particles and 
agglomerates, angular composite, beam 
insensitive
Many particles < 100 nm, but all in 
composites within large particles
100 0.33 < 100 nm, 121.9 2.6
G 62.5 nm to > 10 μm, single particles and 
agglomerates, irregular, solid, beam 
insensitive
Very few separate particles, unclear if 
larger particles are agglomerates of 
nano  particles
100 0.33 156.8 2.6
E 23.3 nm to > 12.8 μm, single particles and 
  agglomerates, spheroidal, solid, beam 
insensitive
Many agglomerated and attached to 
the surface of large particles
100 0.33 17.5, 61.5, 76.4, 
135.8, 181.1, 429.4
3.3
aTEM range of particle diameters, agglomeration, shape, structure, electron beam sensitivity. bNanoproduct based on the Woodrow Wilson Nanotechnology Consumer Products 
Inventory (Woodrow Wilson International Center for Scholars 2011a).
Figure 3. Size distributions of cosmetic powders by number as measured by the Mastersizer 2000. The data 
represent averages of three repeats.
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are usually not the focus of most toxicology 
studies involving nanomaterials. A similar 
phenomenon could be predicted for many 
other nanotechnology­based consumer prod­
ucts that release nano  particles as agglomerates 
and/or as composites with larger particles.
Most toxicological studies of potential 
health effects of inhaled nano  particles, includ­
ing studies of murine models, have used 
aerosols in which individual nano  particles 
or nanosize agglomerates are a dominant 
  fraction. For example, Geiser et al. (2005) 
administered a pure conditioned titanium 
dioxide aerosol with a 22­nm count median 
diameter into the rat respiratory system 
through an endo  tracheal tube. Sayes et al. 
(2010) used a freshly generated silica aerosol 
with 37­ and 83­nm mode diameter aerosols 
for nose inhalation exposure of rats. Based on 
size, such particles would primarily deposit in 
deep regions of the respiratory system.
By contrast, in consumer products such 
as cosmetic powders, our findings suggest 
that primary particles would likely coagulate 
among themselves and with other ingredients 
present in the product before its application. 
As a result, aerosols produced when cosmetic 
powders are used may be dominated by 
much larger particles, including agglomerates 
≥ 10 μm in diameter. Consequently, applica­
tion of cosmetic powders may result in inhaled 
nanomaterial deposition not only in the gas­
exchange region of the lung (alveoli) but also 
in the non–gas­exchange regions (tracheo­
bronchial and head airways). For example, 
nano  particles ≤ 100 nm may form agglom­
erates > 10 μm (supercoarse­size particles) 
that deposit much higher up in the respira­
tory system than do non  agglomerated nano­
particles, that is, in the head airways rather 
than the alveolar and tracheobronchial regions 
(International Commission on Radiological 
Protection 1994), resulting in completely dif­
ferent health effects. Use of pure nano  materials, 
as in the experimental studies cited above, 
would lead to a much higher nanomaterial 
deposition in the deeper regions of the respira­
tory system than could be expected based on 
product exposure simulation. As a result, such 
studies would have a diminished capacity to 
predict human health effects due to exposure 
to actual nanotech  nology­based products.
The combined surface area of nano  particle 
agglomerates exceeds that of solid particles of 
the same size by orders of magnitude. Thus, 
such agglomerates would present a much 
higher potential for surface­based reactiv­
ity within live tissue, potentially leading to 
greater health risks compared with solid par­
ticles of the same size (Brown et al. 2001; 
Duffin et al. 2007; Gwinn and Vallyathan 
2006; Monteiller et al. 2007; Nel et al. 2006).
At the same time, depending on the 
breathing rate, the laryngeal jet may break up 
inhaled loose agglomerates as small as 1 μm in 
diameter (Li et al. 1996) into smaller aggre­
gates or individual particles that could deposit 
throughout the entire respiratory system. 
Therefore, quantitative nano  particle exposure 
studies should take into account the poly­
disperse nature of aerosol produced during 
the use of nanotechnology­based consumer 
products and examine not only the exposure 
to and deposition of unbound nano  particles, 
but also the fate, transport, and deposition of 
nano  particle agglomerates in all regions of the 
respiratory system, including smaller aggre­
gates or particles that may result from the 
breakup of larger nano  particle agglomerates.
Our findings on potential nanomaterial 
inhalation exposure due to the use of actual 
consumer products emphasize that properties 
and effects of the pure nanomaterial ingre­
dients cannot be used to predict actual con­
sumer exposures and resulting health effects. 
Therefore, experimental techniques for toxicity 
studies of de facto nanotechnology­based con­
sumer products must be developed. Results 
of such studies will provide guidance for the 
developing market of nanotechnology­based 
Figure 4. Size distributions of airborne cosmetic powders by number during their application to human 
mannequin face. The data represent averages of three repeats. (A) Electric mobility diameter measured 
by the SMPS: 14.1–723 nm measurement size range. (B) Aerodynamic diameter measured by the APS: 
0.6–19.8 μm measurement size range. Error bars represent ± 1 SD. 
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consumer products and help clarify the need 
and feasibility of its regulation.
We performed our measurements indoors 
at comfortable relative humidity levels: 
40–50%. Application of the powders at dif­
ferent humidity conditions, especially at very 
low or very high levels, could possibly affect 
the extent of powder agglomeration and thus 
its deposition in the respiratory system. The 
effect of relative humidity and other environ­
mental conditions on the extent of exposures 
should be addressed in future studies.
Conclusions
The release of particles > 100 nm and as large 
as 20 μm in diameter indicates potential expo­
sure to nano  particle agglomerates, especially 
from products in which a very large propor­
tion of primary particles are in the nanosize 
range (e.g., nanopowders M and K and regu­
lar powder E, as shown by the TEM).
TEM observations and aerosol measure­
ments suggest that exposure to nanomaterial(s) 
due to the use of cosmetic powders will be 
predominantly in the form of agglomerates 
or nanomaterials attached to larger particles 
that would deposit in the upper airways of the 
human respiratory system rather than in the 
alveolar and tracheobronchial regions of the 
lung, as would be expected based on the size 
of the primary nano  particles. This may lead to 
completely different health effects than expected 
on the basis of nano  particle behavior and toxi­
cology studies for the alveolar region. Thus, 
predominant deposition of nano  materials in the 
upper airways must be taken into account when 
designing inhalation toxicology studies of actual 
consumer products.
We conclude that the use of de facto 
nano  technology­based cosmetic powders has 
a strong potential to result in inhalation expo­
sure to single and agglomerated nano  particles 
and that this potential should be quantitatively 
described by exposure assessment studies.
The absence of information regarding the 
engineered status of nanomaterials in con­
sumer products and difficulties in determining 
whether engineered nanomaterials are pres­
ent point to the need for legislation requiring 
manufacturers to report the use of engineered 
nanomaterials in their products. It is also 
important to determine whether nanosize 
particles present in some consumer products 
may be the result of a manufacturing process 
rather than a consequence of the deliberate 
introduction of engineered nanomaterial(s) 
into the products.
This study provides an example of 
data acquisition methodology that could 
be used in quantitative exposure studies of 
  nanotechnology­based consumer products, 
especially when simulating realistic exposure 
scenarios. Results from such studies could 
be used to estimate exposures resulting from 
the short­term and long­term use of cosmetic 
powders and to design future studies of nano­
particle deposition in the respiratory system 
and inhalation toxicology experiments.
RefeRences
Baroli B. 2009. Penetration of nano  particles and nanomaterials 
in the skin: fiction or reality? J Pharm Sci 99(1):21–50.
Baroli B, Ennas MG, Loffredo F, Isola M, Pinna R, López-
Quintela MA. 2007. Penetration of metallic nano  particles in 
human full-thickness skin. J Invest Dermatol 127:1701–1712.
Bermudez E, Mangum JB, Wong BA, Asgharian B, Hext PM, 
Warheit DB, et al. 2004. Pulmonary responses of mice, 
rats, and hamsters to subchronic inhalation of ultrafine 
titanium dioxide particles. Toxicol Sci 77:347–357.
Bradford A, Handy RD, Readman JW, Atfield A, Mühling M. 
2009. Impact of silver nano  particle contamination on the 
genetic diversity of natural bacterial assemblages in estu-
arine sediments. Environ Sci Technol 43(12):4530–4536.
Brown DM, Wilson MR, MacNee W, Stone V, Donaldson K. 
2001. Size-dependent proinflammatory effects of ultrafine 
polystyrene particles: a role for surface area and oxidative 
stress in the enhanced activity of ultrafines. Toxicol Appl 
Pharmacol 175(3):191–199.
Crosera M, Bovenzi M, Maina G, Adami G, Zanette C, Florio C, 
et al. 2009. Nanoparticle dermal absorption and toxicity: 
a review of the literature. Int Arch Occup Environ Health 
82:1043–1055.
Drobne D. 2007. Nanotoxicology for safe and sustainable nano-
technology. Arh Hig Rada Toksikol 58(4):471–478.
Duffin R, Tran L, Brown D, Stone V, Donaldson K. 2007. 
Proinflammogenic effects of low-toxicity and metal nano-
particles in vivo and in vitro: highlighting the role of par-
ticle surface area and surface reactivity. Inhal Toxicol 
19(10):849–856.
Frater L, Stokes E, Lee R, Oriola T. 2006. An Overview of the 
Framework of Current Regulation Affecting the Develop-
ment and Marketing of Nanomaterials. Cardiff, UK:Cardiff 
University.
Geiser M, Rothen-Rutishauser B, Kapp N, Schürch S, Kreyling W, 
Schulz H, et al. 2005. Ultrafine particles cross cellular mem-
branes by nonphagocytic mechanisms in lungs and in cul-
tured cells. Environ Health Perspect 113:1555–1560.
Gillespie JB, Lindberg JD. 1992. Ultraviolet and visible imagi-
nary refractive index of strongly absorbing atmospheric 
particulate matter. Appl Opt 31(12):2112–2115.
Gwinn MR, Vallyathan V. 2006. Nanoparticles: health effects—
pros and cons. Environ Health Perspect 114:1818–1825.
Hagendorfer H, Lorenz C, Kaegi R, Sinnet B, Gehrig R, Goetz NV, 
et al. 2010. Size-fractionated characterization and quan-
tification of nano  particle release rates from a consumer 
spray product containing engineered nano  particles. 
J Nanopart Res 12(7):2481–2494.
Hansen SF, Michelson ES, Kamper A, Borling P, Stuer-
Lauridsen F, Baun A. 2008. Categorization framework to 
aid exposure assessment of nanomaterials in consumer 
products. Ecotoxicology 17:438–447.
Hinds WC. 1999. Aerosol Technology: Properties, Behavior, 
and Measurement of Airborne Particles. 2nd ed. New 
York:John Wiley & Sons.
Holgate ST. 2010. Exposure, uptake, distribution and toxic-
ity of nanomaterials in humans. J Biomed Nanotechnol 
6(1):1–19.
International Commission on Radiological Protection. 1994. 
Human respiratory tract model for radiological protection. 
A report of a Task Group of the International Commission 
on Radiological Protection. Ann ICRP 24(1–3):1–482.
Johnston HJ, Hutchison G, Christensen FM, Peters S, Hankin S, 
Stone V. 2010. A review of the in vivo and in vitro toxicity of 
silver and gold particulates: particle attributes and biologi-
cal mechanisms responsible for the observed toxicity. Crit 
Rev Toxicol 40(4):328–346.
Jones R. 2002. Successful particle size analysis of dry powders. 
GIT Lab J 6(2):46–48.
Keenan CR, Goth-Goldstein R, Lucas D, Sedlak DL. 2009. 
Oxidative stress induced by zero-valent iron nano  particles 
and Fe(II) in human bronchial epithelial cells. Environ Sci 
Technol 43(12):4555–4560.
Kessler R. 2011. Engineered nano  particles in consumer prod-
ucts: understanding a new ingredient. Environ Health 
Perspect 119:A120–A125.
Larese FF, D’Agostin F, Crosera M, Adami G, Renzi N, 
Bovenzi M, et al. 2009. Human skin penetration of silver 
nano  particles through intact and damaged skin. Toxicology 
255(1–2):33–37.
Li W-I, Perzl M, Heyder J, Langer R, Brain JD, Englmeier K-H, 
et al. 1996. Aerodynamics and aerosol particle deaggre-
gation phenomena in model oral-pharyngeal cavities. 
J Aerosol Sci 27(8):1269–1286.
Lioy PJ. 2010. Exposure science: a view of the past and 
major milestones for the future. Environ Health Perspect 
118:1081–1090.
Lioy PJ, Nazarenko Y, Han TW, Lioy MJ, Mainelis G. 2010. 
Nanotechnology and exposure science—what is needed 
to fill the research and data gaps for consumer products. 
Int J Occup Environ Health 16(4):376–385.
Lioy PJ, Pellizzari E, Prezant D. 2006. The World Trade Center 
aftermath and its effects on health: understanding and 
learning through human-exposure science. Environ Sci 
Technol 40(22):6876–6885.
Malvern Instruments Ltd. 2011. Laser Diffraction Particle Sizing. 
Available: http://www.malvern.com/LabEng/technology/
laser_diffraction/particle_sizing.htm [accessed 11 January 
2011].
Marambio-Jones C, Hoek E. 2010. A review of the antibacterial 
effects of silver nanomaterials and potential implications 
for human health and the environment. J Nanopart Res 
12(5):1531–1551.
Matyi RJ, Schwartz LH, Butt JB. 1987. Particle size, particle 
size distribution, and related measurements of supported 
metal catalysts. Catalysis Rev 29(1):41–99.
Maynard AD. 2007. Nanotechnology: the next big thing, or 
much ado about nothing. Ann Occup Hyg 51(1):1–12.
Maynard AD, Aitken RJ. 2007. Assessing exposure to airborne 
nanomaterials: current abilities and future requirements. 
Nanotoxicology 1(1):26–41.
Maynard AD, Aitken RJ, Butz T, Colvin C, Donaldson K, 
Oberdörster G, et al. 2006. Safe handling of   nanotechnology. 
Nature 444:267–269.
Michelson ES. 2008. Globalization at the nano frontier: the 
future of nanotechnology policy in the United States, 
China, and India. Technol Society 30:405–410.
Monteiller C, Tran L, MacNee W, Faux S, Jones A, Miller B, 
et al. 2007. The pro-inflammatory effects of low-toxicity 
low-solubility particles, nano  particles and fine particles, 
on epithelial cells in vitro: the role of surface area. Occup 
Environ Med 64:609–615.
Nazarenko Y, Han TW, Lioy PJ, Mainelis G. 2011. Potential 
for exposure to engineered nano  particles from nano-
technology-based consumer spray products. J Expo Sci 
Environ Epidemiol 21:515–528.
Nel A, Xia T, Mädler L, Li N. 2006. Toxic potential of materials at 
the nanolevel. Science 311:622–627.
Nowack B, Bucheli TD. 2007. Occurrence, behavior and effects of 
nano  particles in the environment. Environ Pollut 150(1):5–22.
Oberdörster G, Maynard A, Donaldson K, Castranova V, 
Fitzpatrick J, Ausman K, et al. 2005a. Principles for charac-
terizing the potential human health effects from exposure 
to nanomaterials: elements of a screening strategy. Part 
Fibre Toxicol 2:8; doi:10.1186/1743-8977-2-8 [Online 6 October 
2005].
Oberdörster G, Oberdörster E, Oberdörster J. 2005b. 
Nanotoxicology: an emerging discipline evolving from 
studies of ultrafine particles. Environ Health Perspect 
113:823–839.
Ostrowski AD, Martin T, Conti J, Hurt I, Harthorn BH. 2009. 
Nanotoxicology: characterizing the scientific literature, 
2000–2007. J Nanoparticle Res 11:251–257.
Paull J, Lyons K. 2008. Nanotechnology: the next challenge for 
organics. J Organic Syst 3(1):3–22.
Riediker M. 2009. Chances and risks of nanomaterials 
for health and environment. In: Lecture Notes of the 
Institute for Computer Sciences, Social-Informatics and 
Telecommunications Engineering, Vol 20 (Schmid A, Goel S, 
Wang W, Beiu V, Carrara S, eds). Heidelberg:Springer, 
128–133. Available: http://www.scribd.com/kentme/
d/28491514-Lecture-Notes-of-the-Institute-for-Computer 
[accessed 11 January 2011].
Savolainen K, Alenius H, Norppa H, Pylkkänen L, Tuomi T, 
Kasper G. 2010. Risk assessment of engineered nano-
materials and nanotechnologies—a review. Toxicology 
269(2–3):92–104.
Sayes CM, Reed KL, Glover KP, Swain KA, Ostraat ML, 
Donner EM, et al. 2010. Changing the dose metric for 
inhalation toxicity studies: short-term study in rats with Nazarenko et al.
892  v o l u m e  120 | n u m b e r 6 | June 2012  •  Environmental Health Perspectives
engineered aerosolized amorphous silica nano  particles. 
Inhal Toxicol 22(4):348–354.
Schilling K, Bradford B, Castelli D, Dufour E, Nash JF, Pape W, 
et al. 2010. Human safety review of “nano” titanium diox-
ide and zinc oxide. Photochem Photobiol Sci 9(4):495–509.
Segal SH. 2004. Environmental regulation of nanotechnology: 
avoiding big mistakes for small machines. Nanotechnol 
Law Bus 1(3):290–304.
Senzui M, Tamura T, Miura K, Ikarashi Y, Watanabe Y, Fujii M. 
2010. Study on penetration of titanium dioxide (TiO2) nano-
particles into intact and damaged skin in vitro. J Toxicol 
Sci 35(1):107–113.
Shimada M, Wang W-N, Okuyama K, Myojo T, Oyabu T, 
Morimoto Y, et al. 2009. Development and evaluation of 
an aerosol generation and supplying system for inhalation 
experiments of manufactured nano  particles. Environ Sci 
Technol 43(14):5529–5534.
Shrader-Frechette K. 2007. Nanotoxicology and ethical condi-
tions for informed consent. Nanoethics 1:47–56.
Som C, Berges M, Chaudhry Q, Dusinska M, Fernandes T, Olsen S, 
et al. 2010. The importance of life cycle concepts for the 
development of safe nanoproducts. Toxicology 269:160–169.
Thomas T, Bahadori T, Savage N, Thomas K. 2009. Moving 
toward exposure and risk evaluation of nanomaterials: 
challenges and future directions. Wiley Interdiscip Rev 
Nanomed Nanobiotechnol 1(4):426–433.
U.S. Environmental Protection Agency. 1997. Exposure Factors 
Handbook. EPA/600/P-95/002Fa,b,c. Washington, DC:U.S. 
Environmental Protection Agency.
Van Calster G. 2006. Regulating nanotechnology in the European 
Union. Nanotechnol Law Bus 3(3):359–374.
Wardak A, Gorman ME, Swami N, Deshpande S. 2008. 
Identification of risks in the life cycle of nanotechnology-
based products. J Ind Ecol 12(3):435–448.
Warheit DB, Borm PJA, Hennes C, Lademann J. 2007. Testing 
strategies to establish the safety of nanomaterials: conclu-
sions of an ECETOC workshop. Inhal Toxicol 19:631–643.
Warheit DB, Brock WJ, Lee KP, Webb TR, Reed KL. 2005. 
Comparative pulmonary toxicity inhalation and instillation 
studies with different TiO2 particle formulations: impact 
of surface treatments on particle toxicity. Toxicol Sci 
88(2):514–524.
Woodrow Wilson International Center for Scholars. 2011a. 
The Project on Emerging Nanotechnologies: Consumer 
Products: An Inventory of Nanotechnology-Based Consumer 
Products Currently on the Market. Available: http://www.
nanotechproject.org/inventories/consumer/ [accessed 
7 January 2011].
Woodrow Wilson International Center for Scholars. 2011b. The 
Project on Emerging Nanotechnologies: News. Available: 
http://www.nanotechproject.org/ [accessed 26 May 2011].